Legal challenges put off label use of gender affirming care drugs in jeopardy
Pharmaceutical Technology
MARCH 16, 2023
Dr. Barry DeCoster, PhD, an associate professor of bioethics at the University of Michigan, describes gender affirming care as “safe and effective” for most patients. Most drugs used here are prescribed off-label, and experts say pharmaceutical companies remain hesitant to conduct clinical trials studying gender-affirming care.
144 
Let's personalize your content